IBM stock climbs as Jefferies turns bullish and lifts target to $360
5 January 2026
1 min read

IBM stock climbs as Jefferies turns bullish and lifts target to $360

New York, Jan 5, 2026, 14:09 (EST) — Regular session

  • IBM shares rose on fresh bullish calls from Jefferies and RBC Capital.
  • Jefferies upgraded the stock to Buy and lifted its price target to $360.
  • Investors are looking ahead to IBM’s Jan. 28 earnings update for 2026 demand signals.

International Business Machines (IBM.N) shares rose 1.6% to $296.24 in afternoon trading on Monday, after Jefferies upgraded the stock and RBC Capital raised its price target. The shares traded between $293.00 and $299.18 on the day.

The upbeat calls land as Wall Street starts to reset 2026 expectations for enterprise software and spending on artificial intelligence tools. For IBM, the next test is whether its software and hybrid-cloud businesses can keep growing fast enough to justify a premium multiple.

Jefferies upgraded IBM to Buy from Hold and raised its price target — an analyst’s estimate of where a stock could trade over the next 12 months — to $360 from $300. The broker said it is repositioning its software coverage for 2026, arguing that infrastructure software should hold up better than application software early in the year. 1

Jefferies analyst Brent Thill wrote: “These moves strengthen IBM’s hybrid cloud and data platform capabilities, creating cross-sell opportunities and expanding its open-source monetization muscle.” 2

RBC Capital also lifted its price target on IBM to $350 from $300 and kept an Outperform rating, meaning it expects the stock to beat the broader market. The firm said enterprise spending appears to be stabilizing, with generative AI — systems that produce text, code or images — pushing more experimentation even as management teams stay cautious in early-2026 guidance. 3

IBM outperformed a broadly higher market on Monday. The S&P 500 proxy SPY rose about 0.8% and the Nasdaq proxy QQQ gained about 0.9%, while Oracle (ORCL.N) fell 1.0% and Adobe (ADBE.O) slipped 0.2%.

The analyst optimism also leans on IBM’s deal-led software push. IBM last month agreed to buy Confluent for $11 billion in cash, a transaction it said is expected to close by mid-2026, adding real-time data-streaming capabilities aimed at enterprise AI deployments. 4

From a chart perspective, IBM is still below its 52-week high of $324.90 and well above its 52-week low of $214.50, leaving the round-number $300 level in focus for short-term traders. 5

But the upside case depends on execution. If corporate IT budgets soften, or if AI projects fail to convert into repeatable software revenue, IBM’s software growth narrative could lose traction; regulatory delays or integration challenges around the Confluent deal would add another overhang.

Next up is IBM’s fourth-quarter earnings announcement, scheduled for Jan. 28 (preliminary date). Investors will be watching for 2026 demand commentary, software growth trends and any timeline updates on major integration work tied to pending acquisitions. 6

Stock Market Today

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

8 February 2026
Sungrow closed at 144.50 yuan, down 1.03%, after stating it has no plans in the commercial space sector. Mainland China trading resumes Monday, with Spring Festival closures set for Feb. 15–23. Major funds were net sellers of 5.46 billion yuan on Feb. 6. The Shenzhen-listed solar firm remains under scrutiny as investors await further filings before the holiday.
MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

8 February 2026
Monolithic Power Systems shares surged 6.4% to $1,229.82 Friday, hitting a new 52-week high after raising its dividend to $2.00 and forecasting first-quarter revenue of $770 million to $790 million. CEO Michael Hsing filed a Rule 144 notice for 3,082 shares. CFO Bernie Blegen will retire after the 2025 annual report, with Rob Dean named interim CFO. Fourth-quarter revenue rose 20.8% to $751.2 million.
Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

8 February 2026
Microchip Technology shares fell 2.6% to $76.01 Friday after its outlook and analyst reactions disappointed some investors. The company reported fiscal Q3 net sales up 15.6% to $1.186 billion and guided March-quarter sales to $1.24–$1.28 billion. A global memory shortage has disrupted orders, and analysts remain split on recovery prospects. BlackRock disclosed a 10% stake as of Jan. 31.
Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723

Renesas stock price jumps again as $3 billion SiTime deal keeps traders hooked on 6723

8 February 2026
Renesas shares closed at 2,957.5 yen on Friday, up 6.9% after announcing a $3 billion cash-and-stock deal to transfer its timing business to SiTime, with closing targeted by end-2026. Renesas forecast March-quarter revenue of 367.5–382.5 billion yen and a 58.5% gross margin. The company reported 2025 revenue of 1.32 trillion yen and a non-GAAP profit of 329.3 billion yen.
D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026
Previous Story

D-Wave Quantum stock jumps nearly 10% as options bets build ahead of CES 2026

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus
Next Story

Wave Life Sciences stock drops 8% as JPM Healthcare Conference looms; obesity data in focus

Go toTop